Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Krudwig, Wilfried K.
Affiliations: Marienhospital Erwitte, 59597 Erwitte, Germany
Note: [] Correspondence to: Wilfried K. Krudwig, Marienhospital, Von‐Droste‐Str. 14, D‐59597 Erwitte, Germany. Tel.: +49 2943 890 872; Fax: +49 2943 890 549.
Abstract: Between April 1989 and July 1996, 217 anterior cruciate ligament reconstructions using a synthetic ligament of polyethylene terephthalate (PET Trevira® – hochfest) were performed. 160 (74%) cases have been followed‐up with a mean time of 4.8 years (1.0–8.3) and evaluated by the IKDC standard knee ligament evaluation form. Altogether 88% excellent and good results were found. The best outcomes involved isolated ACL tears and reconstruction within a few month. The amount and intensity of lasting symptoms depended mostly on osteoarthrotic changes (chondral and meniscal lesions) and correlated with the interval between injury and reconstruction. All findings are presented in detail and critically discussed.
Keywords: Anterior cruciate ligament, reconstruction, synthetic graft
Journal: Bio-Medical Materials and Engineering, vol. 12, no. 1, pp. 59-67, 2002
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]